Dolby Laboratories (NYSE:DLB – Get Free Report) SVP John Couling sold 7,666 shares of the stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $55.62, for a total transaction of $426,382.92. Following the sale, the senior vice president owned 118,727 shares in the company, valued at $6,603,595.74. This represents a 6.07% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Dolby Laboratories Trading Down 1.5%
NYSE DLB opened at $54.04 on Friday. The firm has a market capitalization of $5.11 billion, a price-to-earnings ratio of 21.36 and a beta of 0.81. The firm’s 50 day simple moving average is $59.06 and its 200 day simple moving average is $62.70. Dolby Laboratories has a 1 year low of $52.45 and a 1 year high of $77.00.
Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating the consensus estimate of $1.31 by $0.06. The business had revenue of $395.63 million during the quarter, compared to the consensus estimate of $385.80 million. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The firm’s revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.34 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, equities research analysts forecast that Dolby Laboratories will post 3.21 earnings per share for the current year.
Dolby Laboratories Announces Dividend
Analyst Ratings Changes
Several equities analysts recently commented on the stock. Barrington Research reissued an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday, April 27th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Finally, Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $90.75.
Check Out Our Latest Analysis on DLB
Hedge Funds Weigh In On Dolby Laboratories
Large investors have recently modified their holdings of the business. Teacher Retirement System of Texas raised its stake in shares of Dolby Laboratories by 19.1% during the fourth quarter. Teacher Retirement System of Texas now owns 115,772 shares of the electronics maker’s stock valued at $7,435,000 after acquiring an additional 18,579 shares during the last quarter. Ashton Thomas Private Wealth LLC bought a new position in shares of Dolby Laboratories during the third quarter valued at $615,000. JPMorgan Chase & Co. raised its stake in shares of Dolby Laboratories by 81.3% during the third quarter. JPMorgan Chase & Co. now owns 312,028 shares of the electronics maker’s stock valued at $22,582,000 after acquiring an additional 139,900 shares during the last quarter. Alps Advisors Inc. raised its stake in shares of Dolby Laboratories by 6.7% during the third quarter. Alps Advisors Inc. now owns 281,532 shares of the electronics maker’s stock valued at $20,374,000 after acquiring an additional 17,592 shares during the last quarter. Finally, Clifford Capital Partners LLC raised its stake in shares of Dolby Laboratories by 15.2% during the third quarter. Clifford Capital Partners LLC now owns 304,311 shares of the electronics maker’s stock valued at $22,023,000 after acquiring an additional 40,252 shares during the last quarter. Institutional investors own 58.56% of the company’s stock.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Articles
- Five stocks we like better than Dolby Laboratories
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
